| Nowack, Amy; Malarkey, Erik B; Yao, Jia et al. (2011) Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS One 6:e29560 |
| Sgro, Allyson E; Nowak, Amy L; Austin, Naola S et al. (2011) A high-throughput method for generating uniform microislands for autaptic neuronal cultures. J Neurosci Methods 198:230-5 |
| Nowack, Amy; Yao, Jia; Custer, Kenneth L et al. (2010) SV2 regulates neurotransmitter release via multiple mechanisms. Am J Physiol Cell Physiol 299:C960-7 |
| Yao, Jia; Nowack, Amy; Kensel-Hammes, Patricia et al. (2010) Cotrafficking of SV2 and synaptotagmin at the synapse. J Neurosci 30:5569-78 |
| Morgans, Catherine W; Kensel-Hammes, Patricia; Hurley, James B et al. (2009) Loss of the Synaptic Vesicle Protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina. PLoS One 4:e5230 |
| Yao, Jia; Bajjalieh, Sandra M (2009) SVOP is a nucleotide binding protein. PLoS One 4:e5315 |
| Yao, Jia; Bajjalieh, Sandra M (2008) Synaptic vesicle protein 2 binds adenine nucleotides. J Biol Chem 283:20628-34 |
| Custer, Kenneth L; Austin, Naola S; Sullivan, Jane M et al. (2006) Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26:1303-13 |
| Schivell, Amanda E; Mochida, Sumiko; Kensel-Hammes, Patricia et al. (2005) SV2A and SV2C contain a unique synaptotagmin-binding site. Mol Cell Neurosci 29:56-64 |
| Lynch, Berkley A; Lambeng, Nathalie; Nocka, Karl et al. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101:9861-6 |
Showing the most recent 10 out of 11 publications
